On Sunday evening, Russian news agency Sputnik News reported that Russia has successfully completed the human trail of its vaccine for novel coronavirus. Vadim Tarasov, Director of Institute of Translational Medicine and Biotechnology, Sechenov University told Sputnik News that the vaccine was developed by Gamaleya Institute of Epidemiology and Microbiology Research Centre at Moscow.
The first group of volunteers with 18 people will be discharged on 15 July and the second group with 20 people will be discharged on 20 July. Russian Health Ministry had sanctioned the trial of the vaccine on 16 June.
How were the trials conducted?
Though, World Health Organization (WHO) has put Russia’s vaccine in phase 1 of clinical trials. There are currently 19 vaccines worldwide, which are in human trial stage. Oxford University’s Astrazeneca and China National Pharmaceutical Group’s Sinopharm are the first competitors for the vaccine of novel coronavirus.
Last week, India’s vaccines Covaxin and ZyCov-D were also passed for clinical trials.
As per WHO, it takes months for quality test of a vaccine and it requires thousands of volunteers. Russia’s vaccine still has to get license before being available in market for the cure of the disease which has got the world on a standstill.
Coronavirus positive cases across the world are 12.6 million with 572,004 deaths so far.